| 6.32 0.02 (0.32%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.7 | 1-year : | 8.11 |
| Resists | First : | 6.59 | Second : | 6.94 |
| Pivot price | 6.44 |
|||
| Supports | First : | 6.01 | Second : | 5 |
| MAs | MA(5) : | 6.26  |
MA(20) : | 6.45 |
| MA(100) : | 6.12 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 29 |
D(3) : | 25.9 |
| RSI | RSI(14): 50.8 |
|||
| 52-week | High : | 8.19 | Low : | 5.23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TPVG ] has closed above bottom band by 36.9%. Bollinger Bands are 8.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.35 - 6.38 | 6.38 - 6.4 |
| Low: | 6.19 - 6.21 | 6.21 - 6.24 |
| Close: | 6.27 - 6.32 | 6.32 - 6.36 |
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Thu, 25 Dec 2025
TriplePoint Venture Growth: Be Careful With This 15% Yield (NYSE:TPVG) - Seeking Alpha
Mon, 22 Dec 2025
TriplePoint Venture Growth BDC (NYSE:TPVG) Insider Sajal Srivastava Acquires 25,000 Shares - MarketBeat
Mon, 22 Dec 2025
TriplePoint Venture Growth BDC (NYSE:TPVG) Insider Acquires $181,250.00 in Stock - MarketBeat
Mon, 22 Dec 2025
TriplePoint Venture Growth BDC (NYSE:TPVG) CEO Purchases $181,250.00 in Stock - MarketBeat
Mon, 22 Dec 2025
Insider Buying: TriplePoint Venture Growth BDC (NYSE:TPVG) CEO Acquires $157,500.00 in Stock - MarketBeat
Mon, 22 Dec 2025
TriplePoint Venture Growth CEO Labe buys $338,814 in stock By Investing.com - Investing.com Nigeria
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 40 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 11.4 (%) |
| Shares Short | 2,250 (K) |
| Shares Short P.Month | 2,290 (K) |
| EPS | 0.82 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.78 |
| Profit Margin | 36.2 % |
| Operating Margin | 75.5 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 9.4 % |
| Qtrly Rev. Growth | -14.4 % |
| Gross Profit (p.s.) | 2.31 |
| Sales Per Share | 2.31 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -33.3 % |
| Operating Cash Flow | -41 (M) |
| Levered Free Cash Flow | 21 (M) |
| PE Ratio | 7.61 |
| PEG Ratio | 0 |
| Price to Book value | 0.71 |
| Price to Sales | 2.72 |
| Price to Cash Flow | -6.23 |
| Dividend | 0.23 |
| Forward Dividend | 0 |
| Dividend Yield | 3.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|